Press Releases

Date Title and Summary Additional Formats
Toggle Summary Stephen Hill, ArQule President and CEO, to Join Solvay Pharmaceuticals, Inc. as New President and CEO
Stephen Hill, ArQule President and CEO, to Join Solvay Pharmaceuticals, Inc. as New President and CEO WOBURN, Mass.--(BUSINESS WIRE)--Jan. 30, 2008--Dr. Stephen A. Hill, president and chief executive officer of ArQule, Inc. (NASDAQ: ARQL), has been appointed the new president and chief executive
View HTML
Toggle Summary ArQule Announces Management Changes
Dr. Stephen Hill to Leave Company Conference Call Scheduled for January 8, 2008, 8:30 a.m. Eastern Time
View HTML
Toggle Summary ArQule Provides Clinical Update on E2F-1 Program
ArQule Provides Clinical Update on E2F-1 Program WOBURN, Mass.--(BUSINESS WIRE)--Nov. 29, 2007--ArQule, Inc. (NASDAQ: ARQL) today announced that symptomatic and asymptomatic QTc prolongation, a measure of cardiac function, has been observed in a Phase 1 dose escalation trial with ARQ 171, a second
View HTML
Toggle Summary ArQule, Inc. to Present at BMO Capital Markets Focus on Healthcare Conference on December 4, 2007
Live web cast scheduled for 10:00 a.m. eastern time
View HTML
Toggle Summary ArQule, Inc. to Present at Lazard Capital Markets Fourth Annual Healthcare Conference on November 28, 2007
Live Web Cast Scheduled for 2:30 P.M. Eastern Time
View HTML
Toggle Summary ArQule, Inc. to Present at the MASS Opportunities Conference on November 8, 2007
ArQule, Inc. to Present at the MASS Opportunities Conference on November 8, 2007 WOBURN, Mass.--(BUSINESS WIRE)--Nov. 1, 2007--ArQule, Inc. (Nasdaq: ARQL) today announced that it will present at the MASS Opportunities Investment Conference at the Hilton Logan Airport Hotel on Thursday, November 8,
View HTML
Toggle Summary ArQule Announces Third Quarter Fiscal 2007 Results
Phase 2 trials underway with ARQ 197, c-Met inhibitor Conference call scheduled today at 9 a.m. eastern time
View HTML
Toggle Summary ArQule Announces Initiation of Two Phase 2 Trials with c-Met Inhibitor, ARQ 197
Trials target MiT tumors and pancreatic cancer
View HTML
Toggle Summary ArQule, Inc. to Present at the CIBC and Rodman & Renshaw Healthcare Conferences on November 5-6, 2007
Rodman & Renshaw live web cast scheduled for November 5, 10:35 p.m. eastern time; CIBC live web cast scheduled for November 6, 8:35 a.m. eastern time
View HTML
Toggle Summary ArQule, Inc. to Report Third Quarter 2007 Financial Results on November 1, 2007
Conference call and Webcast scheduled for 9:00 a.m. Eastern Time
View HTML

Questions or Concerns?

Please feel free to contact by one of the methods below

Online Form   Call (781) 994-0300

These archived presentations and related materials are provided for reference by ArQule, Inc. Information contained in the materials was current only as of the date of the event. ArQule, Inc. does not update or delete outdated information contained in these materials, and it expressly disclaims any obligation to do so. The materials are property of ArQule, Inc. and any use, dissemination or republication of the files is prohibited without the express written consent of ArQule, Inc.